Abstract:Human leishmaniasis is an infectious disease caused by Leishmania protozoan parasites. Current chemotherapeutic options against the deadly disease have significant limitations. The ergosterol biosynthetic pathway has been identified as a drug target in Leishmania. However, remarkable differences in the efficacy of antifungal azoles that inhibit ergosterol biosynthesis have been reported for the treatment of leishmaniasis. To better understand the sterol biosynthetic pathway in Leishmania and elucidate the mechanism underlying the differential efficacy of antifungal azoles, we developed a new LC-MS/MS method to study sterol profiles in promastigotes of three Leishmania species, including two L. donovani, one L. major and one L. tarentolae strains. A combination of distinct precursor ion masses and LC retention times allowed for specific detection of sixteen intermediate sterols between lanosterol and ergosterol using the newly developed LC-MS/MS method. Although both posaconazole and fluconazole are known inhibitors of fungal lanosterol 14α-demethylase (CYP51), only posaconazole led to a substantial accumulation of lanosterol in azole-treated L. donovani promastigotes. Furthermore, a key intermediate sterol accumulated by 40- and 7-fold when these parasites were treated with posaconazole and fluconazole, respectively, which was determined as 4α,14α-dimethylzymosterol by high resolution mass spectrometry and NMR spectroscopy. The identification of 4α,14α-dimethylzymosterol supports a branched ergosterol biosynthetic pathway in Leishmania, where lanosterol C4- and C14-demethylation reactions occur in parallel rather than sequentially. Our results suggest that selective inhibition of leishmanial CYP51 is insufficient to effectively prevent parasite growth and dual inhibitors of both CYP51 and the unknown sterol C4-demethylase may be required for optimal antiparasitic effect.

Expression And Homology Modelling Of Sterol 14 Alpha-Demethylase Of Magnaporthe Grisea And Its Interaction With Azoles

Expression and Homology Modeling of Sterol 14Alpha-Demethylase from Magnaporthe Grisea

Expression and Homology Modeling of Sterol 14Alpha-Demethylase from Penicillium Digitatum.

Homology model, molecular dynamics simulation and novel pyrazole analogs design of Candida albicans CYP450 lanosterol 14 α-demethylase, a target enzyme for antifungal therapy

Paralogous Cyp51 Genes in Fusarium Graminearum Mediate Differential Sensitivity to Sterol Demethylation Inhibitors

Comparison and analysis of the structures and binding modes of antifungal SE and CYP51 inhibitors

A sterol 14α-demethylase is required for conidiation, virulence and for mediating sensitivity to sterol demethylation inhibitors by the rice blast fungus Magnaporthe oryzae.

Differential Communications Between Fungi and Host Plants Revealed by Secretome Analysis of Phylogenetically Related Endophytic and Pathogenic Fungi

Functional Analysis of Two Sterol Regulatory Element Binding Proteins in Penicillium Digitatum.

Sterol 14α-Demethylase Ligand-Binding Pocket-Mediated Acquired and Intrinsic Azole Resistance in Fungal Pathogens

Sensitivity of Magnaporthe Grisea to the Sterol Demethylation Inhibitor Fungicide Propiconazole

Antifungal activity of amino-alcohols based cationic surfactants and in silico, homology modeling, docking and molecular dynamics studies against lanosterol 14-α-demethylase enzyme

In silico prediction of Antifungal compounds from Natural sources towards Lanosterol 14-alpha demethylase (CYP51) using Molecular docking and Molecular dynamic simulation

Sterol profiling of Leishmania parasites using a new HPLC-tandem mass spectrometry-based method and antifungal azoles as chemical probes reveals a key intermediate sterol that supports a branched ergosterol biosynthetic pathway

Molecular simulations of fluconazole-mediated inhibition of sterol biosynthesis

Toxic eburicol accumulation drives the antifungal activity of azoles against

The Computational Interaction Analyses of Some Vitamin D-Related Compounds with Sterol 14-Demethylase (CYP51) – Could It Be a Glimmer of Hope to Find New Anti-Mucormycotic Drugs Extracted from Plants-Derived Sterols?

Molecular Dynamics Investigations of Binding Mechanism for Triazoles Inhibitors to CYP51

The discovery of novel antifungal phenylpyridines derivatives based on CYP53 binding model

Analysis of the binding modes and resistance mechanism of four methyl benzimidazole carbamates inhibitors fungicides with Monilinia fructicola β2-tubulin protein

Experimental and Computational Insights of Albizia amara Phytoconstituents Targeting Anthranilate Phosphoribosyltransferase from Malassezia Globosa